Avantor, Inc. (NYSE:AVTR) Receives $27.69 Consensus Target Price from Analysts

Shares of Avantor, Inc. (NYSE:AVTR) have been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $27.69.

A number of equities analysts have recently issued reports on AVTR shares. UBS Group dropped their price target on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research report on Tuesday, October 8th. Wells Fargo & Company dropped their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a report on Monday, October 28th. Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Friday, October 25th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 price objective on shares of Avantor in a research note on Thursday, September 26th. Finally, Robert W. Baird reduced their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th.

Institutional Investors Weigh In On Avantor

A number of large investors have recently modified their holdings of the business. Bank of New York Mellon Corp boosted its stake in Avantor by 1.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 2,325,329 shares of the company’s stock worth $49,297,000 after purchasing an additional 35,497 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Avantor by 35.1% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,157,855 shares of the company’s stock worth $24,547,000 after buying an additional 300,579 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Avantor during the second quarter valued at $2,353,000. Kintegral Advisory LLC acquired a new position in shares of Avantor in the 2nd quarter valued at $514,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Avantor by 2.0% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 359,580 shares of the company’s stock worth $7,623,000 after acquiring an additional 7,156 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Stock Down 1.5 %

Shares of NYSE AVTR opened at $21.08 on Thursday. Avantor has a 52-week low of $19.59 and a 52-week high of $28.00. The firm has a market capitalization of $14.35 billion, a price-to-earnings ratio of 45.83, a PEG ratio of 2.75 and a beta of 1.29. The stock has a 50 day moving average price of $21.80 and a 200 day moving average price of $23.37. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.